A novel personalized test for optimal cholesterol-lowering therapy.
We have developed a unique solution that sheds light on why some people respond differently to cholesterol-lowering drugs, opening new ways for personalized medicine and improving patient lives.
Immediate detection of poor statin responders and their prioritization for more
Multi-purpose analysis platform for the quantification of cellular mechanisms in primary human cells.
Semi-automated process using robotics systems to analyze the samples in our centralized analysis center.
CONTACT US FOR MORE INFORMATION
PILOTS | CLINICAL TRIALS | INVESTMENT | CO-DEVELOPMENT
Haartmaninkatu 8, 02190 Helsinki, Finland.